HDAC6 and ciliopathy: Tubastatin A, an inhibitor of HDAC6, increased ciliogenesis and decreased proliferation of human cholangiocarcinoma cell lines. Tubastatin A also inhibited cholangiocarcinoma growth in a rat model. Tubastatin A induced ciliogenesis in a mouse model of ciliopathy